tetano
Editor, Senior Moderator
Virus Res
. 2022 Mar 16;198745.
doi: 10.1016/j.virusres.2022.198745. Online ahead of print.
Inhibition of avian influenza virus H9N2 infection by antiviral hexapeptides that target viral attachment to epithelial cells
Marwa Arbi[SUP] 1 [/SUP], Imen Larbi[SUP] 1 [/SUP], Jihen Nsiri[SUP] 1 [/SUP], Imen El Behi[SUP] 1 [/SUP], Ahmed Rejeb[SUP] 2 [/SUP], Khaled Miled[SUP] 1 [/SUP], Adeljelil Ghram[SUP] 1 [/SUP], Mehdi Houimel[SUP] 3 [/SUP]
Affiliations
Abstract
The H9N2 subtype of influenza A virus circulates frequently among poultry in Asian and North African countries causing economic loss in the poultry sector. The antigenic variations of the H9N2 virus were at the origin of its genetic evolution through the emergence of viral strains transmissible to humans and resistant to chemical antivirals, which require a strengthening of the fight means against this virus. In this study, we used a random linear hexapeptide library fused to the gene III protein of M13 filamentous bacteriophage to select new antiviral peptides that inhibit the infectivity of H9N2 virus. After three rounds of stringent selection and amplification, polyclonal phage-peptides directed against H9N2 virus were assessed by ELISA, and the optimal phage-peptides were grown individually and characterized for binding to H9N2 virus by monoclonal phage ELISA. The DNA of 27 phage-peptides clones was amplified by PCR, sequenced, and their amino acid sequences were deduced. Sixteen different phage-peptides were able to bind specifically the H9N2 virus, among them, 13 phage-peptides interacted with the hemagglutinin H9. Two selected peptides, P1 (LSRMPK) and P2 (FAPRWR) have shown antiviral activity in ovo and P1 was more protective in vivo then P2 when co-administered with the H9N2 virus. Mechanistically, these peptides prevent infection by inhibiting the attachment of the H9N2 virus to the cellular receptor. Molecular docking revealed that the peptides LSRMPK and FAPRWR bind to hemagglutinin protein H9, but interact differently with the receptor binding site (RBS). The present study demonstrated that the peptide P1 (LSRMPK) could be used as a new inhibitory molecule directed against the H9N2 virus.
Keywords: H9N2 virus; Hemagglutinin; Peptides; Phage display; Receptor binding site.
. 2022 Mar 16;198745.
doi: 10.1016/j.virusres.2022.198745. Online ahead of print.
Inhibition of avian influenza virus H9N2 infection by antiviral hexapeptides that target viral attachment to epithelial cells
Marwa Arbi[SUP] 1 [/SUP], Imen Larbi[SUP] 1 [/SUP], Jihen Nsiri[SUP] 1 [/SUP], Imen El Behi[SUP] 1 [/SUP], Ahmed Rejeb[SUP] 2 [/SUP], Khaled Miled[SUP] 1 [/SUP], Adeljelil Ghram[SUP] 1 [/SUP], Mehdi Houimel[SUP] 3 [/SUP]
Affiliations
- PMID: 35306102
- DOI: 10.1016/j.virusres.2022.198745
Abstract
The H9N2 subtype of influenza A virus circulates frequently among poultry in Asian and North African countries causing economic loss in the poultry sector. The antigenic variations of the H9N2 virus were at the origin of its genetic evolution through the emergence of viral strains transmissible to humans and resistant to chemical antivirals, which require a strengthening of the fight means against this virus. In this study, we used a random linear hexapeptide library fused to the gene III protein of M13 filamentous bacteriophage to select new antiviral peptides that inhibit the infectivity of H9N2 virus. After three rounds of stringent selection and amplification, polyclonal phage-peptides directed against H9N2 virus were assessed by ELISA, and the optimal phage-peptides were grown individually and characterized for binding to H9N2 virus by monoclonal phage ELISA. The DNA of 27 phage-peptides clones was amplified by PCR, sequenced, and their amino acid sequences were deduced. Sixteen different phage-peptides were able to bind specifically the H9N2 virus, among them, 13 phage-peptides interacted with the hemagglutinin H9. Two selected peptides, P1 (LSRMPK) and P2 (FAPRWR) have shown antiviral activity in ovo and P1 was more protective in vivo then P2 when co-administered with the H9N2 virus. Mechanistically, these peptides prevent infection by inhibiting the attachment of the H9N2 virus to the cellular receptor. Molecular docking revealed that the peptides LSRMPK and FAPRWR bind to hemagglutinin protein H9, but interact differently with the receptor binding site (RBS). The present study demonstrated that the peptide P1 (LSRMPK) could be used as a new inhibitory molecule directed against the H9N2 virus.
Keywords: H9N2 virus; Hemagglutinin; Peptides; Phage display; Receptor binding site.
